Log In or Register to Join The Conversation!

Tagged: ,

Viewing 1 reply thread
  • Author
    • #18929
      Forum Moderator

      Ongentys, available in Japan via Ono Pharmaceutical, is an oral add-on daily therapy for those whose motor symptoms return while using levodopa/carbidopa. Read more about it here.

      Have you tried or would you like to try Ongentys?

    • #18978

      Ongentys (opicapone) was recently approved by the FDA as an oral,add-on daily treatment for Parkinson’s patients experiencing off periods while on levodopa. Ongentys increases the amount of levodopa reaching the brain by blocking an enzyme called catechol-o-methyltransferase (COMT),that breaks down levodopa in the blood.  Ongentys was found to be superior to placebo in reducing “off” periods — times when the beneficial effects of levodopa wear off before a new dose can be taken.

      I already take COMTAN (entacapone), a generic COMT-blocking drug. Has Ongentys been compared directly to Comtan in any clinical trials? Is there any reason to believe Ongentys may be more effective at reducing off time, without increasing troublesome dyskinesias? I take Rytary plus Comtan six times per day, and I would welcome replacing those 6 Comtan tablets with a single Ongentys pill, if the symptomatic benefits are equal or better, and the price of Ongentys is not prohibitive compared to Comtan.

Viewing 1 reply thread
  • You must be logged in to reply to this topic.
Copyright © 2017-2020 All rights reserved.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?


Create Account